Literature DB >> 25428803

Evaluation of photodynamic therapy efficiency using an in vitro three-dimensional microfluidic breast cancer tissue model.

Yamin Yang1, Xiaochuan Yang, Jin Zou, Chao Jia, Yue Hu, Henry Du, Hongjun Wang.   

Abstract

In recognition of the limitations of monolayer cell cultures and resource-intensive animal studies, a microfluidic culture system was developed for creation of physiologically relevant three-dimensional (3D) tissues. In this study, an in vitro 3D breast cancer tissue model was established in a microfluidic system with human breast cancer cells (MCF-7) and primary adipose-derived stromal cells (ASCs). It was evaluated for utility in determining the efficiency of photodynamic therapy (PDT) with therapeutic agents (i.e. photosensitizer and gold nanoparticles) under various irradiation conditions. We demonstrated, for the first time, the potential use of a microfluidic-based in vitro 3D breast cancer model for effective evaluation of PDT, with the capability of controlling 3D microenvironments for breast cancer tissue formation, real-time monitoring of tissue progression, implementing a circulation-like dynamic medium flow and drug supplements, and investigating the relation between light penetration and tissue depth in PDT.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25428803     DOI: 10.1039/c4lc01065e

Source DB:  PubMed          Journal:  Lab Chip        ISSN: 1473-0189            Impact factor:   6.799


  23 in total

Review 1.  Apoptosis and associated phenomena as a determinants of the efficacy of photodynamic therapy.

Authors:  David Kessel
Journal:  Photochem Photobiol Sci       Date:  2015-01-05       Impact factor: 3.982

Review 2.  Cancer-on-a-chip systems at the frontier of nanomedicine.

Authors:  Yu Shrike Zhang; Yi-Nan Zhang; Weijia Zhang
Journal:  Drug Discov Today       Date:  2017-04-05       Impact factor: 7.851

Review 3.  Advancing Tumor Microenvironment Research by Combining Organs-on-Chips and Biosensors.

Authors:  Isabel Calejo; Marcel Alexander Heinrich; Giorgia Zambito; Laura Mezzanotte; Jai Prakash; Liliana Moreira Teixeira
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 4.  Progress towards understanding heterotypic interactions in multi-culture models of breast cancer.

Authors:  Mary C Regier; Elaine T Alarid; David J Beebe
Journal:  Integr Biol (Camb)       Date:  2016-04-21       Impact factor: 2.192

Review 5.  Microfluidic models for adoptive cell-mediated cancer immunotherapies.

Authors:  Giulia Adriani; Andrea Pavesi; Anthony T Tan; Antonio Bertoletti; Jean Paul Thiery; Roger D Kamm
Journal:  Drug Discov Today       Date:  2016-05-13       Impact factor: 7.851

Review 6.  Breast cancer models: Engineering the tumor microenvironment.

Authors:  Gokhan Bahcecioglu; Gozde Basara; Bradley W Ellis; Xiang Ren; Pinar Zorlutuna
Journal:  Acta Biomater       Date:  2020-02-09       Impact factor: 8.947

Review 7.  Breast tumor-on-chip models: From disease modeling to personalized drug screening.

Authors:  Bano Subia; Ujjwal Ranjan Dahiya; Sarita Mishra; Jessica Ayache; Guilhem Velve Casquillas; David Caballero; Rui L Reis; Subhas C Kundu
Journal:  J Control Release       Date:  2021-01-06       Impact factor: 9.776

Review 8.  Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling.

Authors:  Aleksander Skardal; Thomas Shupe; Anthony Atala
Journal:  Drug Discov Today       Date:  2016-07-12       Impact factor: 8.369

9.  High-Throughput Cancer Cell Sphere Formation for Characterizing the Efficacy of Photo Dynamic Therapy in 3D Cell Cultures.

Authors:  Yu-Chih Chen; Xia Lou; Zhixiong Zhang; Patrick Ingram; Euisik Yoon
Journal:  Sci Rep       Date:  2015-07-08       Impact factor: 4.379

Review 10.  Animal models for photodynamic therapy (PDT).

Authors:  Zenildo Santos Silva; Sandra Kalil Bussadori; Kristianne Porta Santos Fernandes; Ying-Ying Huang; Michael R Hamblin
Journal:  Biosci Rep       Date:  2015-09-28       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.